HESTERBIO - Hester Biosciences

Hester Biosciences

HESTERBIO · Pharma > Pharmaceuticals & Drugs · Chairman: Bhupendra V Gandhi · MD: Rajiv Gandhi · Listing date: March 13, 2015 · Employees: 428 · Ahmedabad · http://www.hester.in

Stock Price vs Company Growth

7.5%

8.2%

19.4%

26.1%

20.2%

10.9%

5.6%

10y

12.5%

all

14.5%

🤔 How to analyze this graph?

Last Traded Price

₹ 1,990 7.5%

1,251

2,228

Company Overview

Sales

333 Cr

Growth: 4.0%

Profit after Tax

52.7 Cr

Growth: 28.7%

Small Cap

1,693 Cr

P/E: 29.5x

Industry P/E: 31.1x

Fundamentals

Sales (Cr)	₹ 333
Growth	4.0%
EBITDA	26.1%
P/S	5.1x
Dividend	0.3%
P/E	29.5x
Book Value	₹ 423
PEG Ratio	7.4x
ROE	15.2%
P/B	4.7x

Shareholding Pattern

Institutions

Kuntal Hasmukhlal Shah

3.05 %

Manish Jain

2.56 %

Darshna Dinesh Kapadia

1.81 %

Vinay Shah

1.28 %

Iepf

0.89 %

Promoters

Rajiv D Gandhi

10.47 %

Sanjiv Dinesh Gandhi

8.2 %

Nina R Gandhi

8.19 %

Ravin Gandhi

4.74 %

Bela Gandhi

4.71 %

Others

Increase Decrease No change

Company Profile Detailed

Hester Biosciences was incorporated on April 29, 1987 as a Private Limited Company by the name of Hester Pharmaceuticals Limited. It was subsequently converted into a Public Limited Company on November 1, 1993. The company is engaged in the manufacturing of poultry vaccines. The company has been promoted by Rajiv D. Gandhi his brother Sanjiv D. Gandhi and Dr. Bhupendra V. Gandhi. The company changed its name to the present in 2008.

Belongs to (4 Indices)

Investors (50)

non.resi...

anup.kap...

hetal.sa...

Followers (11)

nitin2

keerthi

deepak